Catalyst Wire Dossier Catalyst Wire Dossier

MKC253

MKC253 · MannKind Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MKC253, covering 2012-06-14 to 2012-06-14. Get the full timeline:

Most recent: Clinical Trial Update: A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males [Phase 1]

See pricing